Chih‐Ping Mao

1.1k total citations
18 papers, 824 citations indexed

About

Chih‐Ping Mao is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Chih‐Ping Mao has authored 18 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Chih‐Ping Mao's work include Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (5 papers) and Virus-based gene therapy research (3 papers). Chih‐Ping Mao is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (5 papers) and Virus-based gene therapy research (3 papers). Chih‐Ping Mao collaborates with scholars based in United States, South Korea and China. Chih‐Ping Mao's co-authors include T.‐C. Wu, Chien‐Fu Hung, Tae Woo Kim, Kyung Hee Noh, Tae Heung Kang, Kwon‐Ho Song, Annie A. Wu, Young Ho Lee, Archana Monie and Chi-Mu Chuang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Chih‐Ping Mao

18 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Ping Mao United States 13 410 346 299 116 116 18 824
Jemila C. Kester United States 9 372 0.9× 268 0.8× 324 1.1× 198 1.7× 51 0.4× 11 900
Sreekumar Balan United States 10 434 1.1× 1.0k 2.9× 542 1.8× 62 0.5× 173 1.5× 13 1.3k
Xinhui Wang United States 17 344 0.8× 652 1.9× 318 1.1× 62 0.5× 38 0.3× 29 1.0k
Genc Basha Canada 17 672 1.6× 541 1.6× 216 0.7× 59 0.5× 83 0.7× 28 1.3k
Martine Mazel France 15 451 1.1× 438 1.3× 742 2.5× 481 4.1× 90 0.8× 17 1.4k
Aaron K. Neumann United States 17 526 1.3× 220 0.6× 240 0.8× 172 1.5× 48 0.4× 26 950
Silvia Valensin Italy 13 346 0.8× 225 0.7× 113 0.4× 42 0.4× 42 0.4× 22 659
Rachel Lubong Sabado United States 14 435 1.1× 1.1k 3.2× 517 1.7× 50 0.4× 169 1.5× 37 1.4k
Cedric Mpoy United States 15 230 0.6× 372 1.1× 529 1.8× 105 0.9× 51 0.4× 25 1.0k

Countries citing papers authored by Chih‐Ping Mao

Since Specialization
Citations

This map shows the geographic impact of Chih‐Ping Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Ping Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Ping Mao more than expected).

Fields of papers citing papers by Chih‐Ping Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Ping Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Ping Mao. The network helps show where Chih‐Ping Mao may publish in the future.

Co-authorship network of co-authors of Chih‐Ping Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Ping Mao. A scholar is included among the top collaborators of Chih‐Ping Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Ping Mao. Chih‐Ping Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mao, Chih‐Ping, Yu‐Ping Su, Liangmei He, et al.. (2021). Protein detection in blood with single-molecule imaging. Science Advances. 7(33). 23 indexed citations
2.
Norman, Maia, Tal Gilboa, Alana F. Ogata, et al.. (2020). Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. Nature Biomedical Engineering. 4(12). 1180–1187. 94 indexed citations
3.
Kang, Tae Heung, Chih‐Ping Mao, Young Seob Kim, et al.. (2019). TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 260–260. 41 indexed citations
4.
Mao, Chih‐Ping, Shiwen Peng, Andrew Yang, et al.. (2018). Programmed self-assembly of peptide–major histocompatibility complex for antigen-specific immune modulation. Proceedings of the National Academy of Sciences. 115(17). E4032–E4040. 8 indexed citations
5.
Song, Kwon‐Ho, Chel Hun Choi, Hyo‐Jung Lee, et al.. (2017). HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. Cancer Research. 77(18). 5039–5053. 72 indexed citations
6.
Lee, Young Ho, Hyun Cheol Bae, Kyung Hee Noh, et al.. (2015). Gain of HIF-1α under Normoxia in Cancer Mediates Immune Adaptation through the AKT/ERK and VEGFA Axes. Clinical Cancer Research. 21(6). 1438–1446. 52 indexed citations
7.
8.
Kang, Tae Heung, Chih‐Ping Mao, Sung Yong Lee, et al.. (2013). Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity. Cancer Research. 73(8). 2493–2504. 91 indexed citations
9.
Noh, Kyung Hee, Young‐Ho Lee, Ju‐Hong Jeon, et al.. (2012). Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like Phenotype. Cancer Research. 72(7). 1717–1727. 63 indexed citations
10.
Kang, Tae Heung, et al.. (2012). Innovative DNA Vaccine to Break Immune Tolerance Against Tumor Self-Antigen. Human Gene Therapy. 24(2). 181–188. 10 indexed citations
11.
Noh, Kyung Hee, Bo Wook Kim, Kwon‐Ho Song, et al.. (2012). Nanog signaling in cancer promotes stem-like phenotype and immune evasion. Journal of Clinical Investigation. 122(11). 4077–4093. 152 indexed citations
12.
Kang, Tae Heung, Chih‐Ping Mao, Liangmei He, et al.. (2012). Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects. PLoS ONE. 7(4). e35141–e35141. 41 indexed citations
13.
Mao, Chih‐Ping & T.‐C. Wu. (2010). Inhibitory RNA Molecules in Immunotherapy for Cancer. Methods in molecular biology. 623. 325–339. 10 indexed citations
14.
Mao, Chih‐Ping, Chien‐Fu Hung, Tae Heung Kang, et al.. (2009). Combined Administration with DNA Encoding Vesicular Stomatitis Virus G Protein Enhances DNA Vaccine Potency. Journal of Virology. 84(5). 2331–2339. 8 indexed citations
15.
Chuang, Chi-Mu, Archana Monie, Annie A. Wu, Chih‐Ping Mao, & Chien‐Fu Hung. (2009). Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer. Human Gene Therapy. 20(4). 303–313. 85 indexed citations
16.
Mao, Chih‐Ping, et al.. (2008). RNA Interference-Mediated In Vivo Silencing of Fas Ligand as a Strategy for the Enhancement of DNA Vaccine Potency. Human Gene Therapy. 19(8). 763–773. 26 indexed citations
17.
Mao, Chih‐Ping, et al.. (2007). Immunological research using RNA interference technology. Immunology. 121(3). 295–307. 11 indexed citations
18.
Mao, Chih‐Ping, Chien‐Fu Hung, & T.‐C. Wu. (2006). Immunotherapeutic strategies employing RNA interference technology for the control of cancers. Journal of Biomedical Science. 14(1). 15–29. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jemila C. Kester Breakdown of academic impact, for papers by Sreekumar Balan Breakdown of academic impact, for papers by Xinhui Wang Breakdown of academic impact, for papers by Genc Basha Breakdown of academic impact, for papers by Martine Mazel Breakdown of academic impact, for papers by Aaron K. Neumann Breakdown of academic impact, for papers by Silvia Valensin Breakdown of academic impact, for papers by Rachel Lubong Sabado Breakdown of academic impact, for papers by Cedric Mpoy
Rankless by CCL
2026